Ontology highlight
ABSTRACT:
SUBMITTER: Kleibeuker EA
PROVIDER: S-EPMC4596900 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
Angiogenesis 20150723 4
To improve the efficacy of radiotherapy (RTx), there is a growing interest in combining RTx with drugs that inhibit angiogenesis, i.e., the process of neo-vessel formation out of preexisting capillaries. A frequently used drug to inhibit angiogenesis is sunitinib (Sutent, SU11248), a receptor tyrosine kinase inhibitor that is currently FDA approved for the treatment of several cancer types. The current review presents an overview of the preclinical studies and clinical trials that combined sunit ...[more]